Literature DB >> 3885289

A comparison of the clinical effects of bromperidol, a new butyrophenone derivative, and haloperidol on schizophrenia using a double-blind technique.

H Itoh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3885289

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  3 in total

1.  Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.

Authors:  E Suzuki; S Kanba; H Koshikawa; M Nibuya; G Yagi; M Asai
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

Review 2.  Bromperidol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in psychoses.

Authors:  P Benfield; A Ward; B G Clark; S G Jue
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 3.  Bromperidol decanoate (depot) for schizophrenia.

Authors:  Marianna Purgato; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.